Berliner Boersenzeitung - First Covid vaccine side-effect claims land in German courts

EUR -
AED 4.255899
AFN 72.432944
ALL 95.975736
AMD 435.816867
ANG 2.074448
AOA 1062.670738
ARS 1619.00736
AUD 1.664418
AWG 2.08594
AZN 1.965411
BAM 1.956316
BBD 2.328224
BDT 141.837422
BGN 1.980843
BHD 0.437657
BIF 3428.619402
BMD 1.158856
BND 1.478997
BOB 7.988142
BRL 6.101215
BSD 1.15601
BTN 108.040972
BWP 15.796236
BYN 3.442123
BYR 22713.57276
BZD 2.324923
CAD 1.593809
CDF 2634.079447
CHF 0.912802
CLF 0.026896
CLP 1062.021594
CNY 7.973508
CNH 7.993474
COP 4302.147686
CRC 539.144574
CUC 1.158856
CUP 30.709677
CVE 110.294576
CZK 24.480538
DJF 205.855201
DKK 7.471357
DOP 68.598395
DZD 153.754179
EGP 61.083375
ERN 17.382836
ETB 180.492
FJD 2.575846
FKP 0.865723
GBP 0.865196
GEL 3.146334
GGP 0.865723
GHS 12.646391
GIP 0.865723
GMD 84.596598
GNF 10132.71714
GTQ 8.854374
GYD 241.844852
HKD 9.068017
HNL 30.597205
HRK 7.534884
HTG 151.410602
HUF 390.142677
IDR 19561.832769
ILS 3.618985
IMP 0.865723
INR 108.642205
IQD 1514.39956
IRR 1523953.258404
ISK 143.790433
JEP 0.865723
JMD 182.078825
JOD 0.821607
JPY 183.961977
KES 150.191349
KGS 101.3402
KHR 4632.242159
KMF 492.513609
KPW 1042.936742
KRW 1735.867428
KWD 0.35505
KYD 0.96335
KZT 557.168924
LAK 24847.663027
LBP 103523.360316
LKR 363.007342
LRD 211.546727
LSL 19.601456
LTL 3.4218
LVL 0.70098
LYD 7.399984
MAD 10.804997
MDL 20.218422
MGA 4811.290172
MKD 61.619088
MMK 2433.167084
MNT 4135.923012
MOP 9.326861
MRU 46.146374
MUR 53.891919
MVR 17.904411
MWK 2004.13742
MXN 20.722312
MYR 4.585017
MZN 74.062945
NAD 19.59968
NGN 1592.476153
NIO 42.541408
NOK 11.233374
NPR 172.865355
NZD 1.98862
OMR 0.445586
PAB 1.15601
PEN 4.021461
PGK 4.991338
PHP 69.408484
PKR 322.693232
PLN 4.27397
PYG 7554.02565
QAR 4.227234
RON 5.094316
RSD 117.444213
RUB 93.641229
RWF 1690.053196
SAR 4.350082
SBD 9.330779
SCR 16.087553
SDG 696.472444
SEK 10.811603
SGD 1.483057
SHP 0.869442
SLE 28.449668
SLL 24300.638259
SOS 660.677164
SRD 43.267618
STD 23985.974368
STN 24.506572
SVC 10.114625
SYP 128.606968
SZL 19.594254
THB 37.747988
TJS 11.045462
TMT 4.055995
TND 3.406714
TOP 2.790246
TRY 51.392106
TTD 7.847393
TWD 37.073181
TZS 2978.258958
UAH 50.757111
UGX 4364.170274
USD 1.158856
UYU 47.102631
UZS 14093.718494
VES 529.022698
VND 30543.961084
VUV 138.434854
WST 3.185549
XAF 656.132945
XAG 0.016646
XAU 0.000263
XCD 3.131866
XCG 2.083341
XDR 0.816019
XOF 656.132945
XPF 119.331742
YER 276.560932
ZAR 19.76266
ZMK 10431.128864
ZMW 22.397006
ZWL 373.15108
  • RBGPF

    -13.5000

    69

    -19.57%

  • VOD

    0.0900

    14.57

    +0.62%

  • BP

    0.8690

    44.439

    +1.96%

  • NGG

    0.6100

    82.67

    +0.74%

  • RELX

    -0.7100

    33.1

    -2.15%

  • GSK

    0.2800

    52.27

    +0.54%

  • RYCEF

    -0.5000

    15.55

    -3.22%

  • RIO

    -0.4100

    85.43

    -0.48%

  • CMSD

    -0.0700

    22.67

    -0.31%

  • JRI

    0.1600

    11.84

    +1.35%

  • BCE

    0.1450

    25.905

    +0.56%

  • CMSC

    -0.0850

    22.795

    -0.37%

  • BTI

    0.0000

    57.92

    0%

  • BCC

    0.5300

    72.41

    +0.73%

  • AZN

    0.2100

    184.28

    +0.11%

First Covid vaccine side-effect claims land in German courts

First Covid vaccine side-effect claims land in German courts

Vaccine-maker BioNTech faced Monday its first legal claim in its home country of Germany over adverse effects allegedly suffered by some users of its Covid vaccines, more than two years after one of the world's fastest and most extensive inoculation campaigns.

Text size:

In the face of the deadly pandemic that emerged in early 2020, which prompted border closures and lockdowns that trapped millions of people in their homes, the arrival of Covid vaccines had been widely hailed as a life-saver.

But the jabs, which had been developed at breakneck speed and granted early approval for usage, are now the focus of legal procedures in several countries including France and Britain where plaintiffs argue that the vaccines harmed their health.

In Germany, a court in Hamburg was prepared to hear a case from Monday against BioNTech, which, together with US giant Pfizer, produced the first mRNA vaccine Comirnaty.

The hearing was delayed however after the claimant's lawyers put in a last-minute challenge of the judge's impartiality, and asking instead for a panel of judges to rule on the case.

In her claim, the plaintiff reported suffering effects including "pain in the upper body, swelling of the extremities, exhaustion, fatigue and sleeping disorders" after receiving the vaccine, the court said.

She is seeking 150,000 euros ($162,000) in damages and recognition that the "defendant is bound to provide material damages", the court added.

Her lawyer Thomas Ulbrich, who is also representing another 250 people in similar cases, said his clients were "all healthy" before suffering from symptoms, allegedly following their jabs.

He believes that the medical files he has on hand offer a link between the vaccines and the symptoms experienced by his clients.

- 'Rocky and long road' -

BioNTech's mRNA vaccine, a scientific breakthrough, had been granted conditional marketing authorisation as early as December 21, 2020, by the EU regulatory authority EMA.

Similar authorisation for Moderna, another mRNA vaccine maker, swiftly followed.

With fears of catching the disease running high, the vaccines were pre-ordered by governments even during their development phases, and deployment swiftly followed once regulatory authorities gave their approval.

But the new generation of inoculations also sparked a wave of vaccine sceptics questioning the safety of the jabs.

Out of 192 million jabs given in Germany, the country's medicines regulator, the Paul Ehrlich Institute, said 338,857 suspected cases of side effects were reported, including 54,879 severe reactions.

Among the worst cases, "the symptoms are very different, they vary from stroke to thrombosis to cardiac diseases", said another German lawyer, Joachim Caesar-Preller, who represents 140 clients making similar claims.

He is seeking up to one million euros in damages per case -- plus interest -- but concedes that a "rocky and long road" lies ahead in the legal battles.

- 'Not an isolated case' -

A key point for the courts is whether the side effects of the medication, when used correctly, surpass "a justifiable level according to the findings of medical science".

In other words, the effects have to be sufficiently serious to be taken into account, said Anatol Dutta, a professor at Munich University.

A claimant identified only as Kathrin K., 45, believes her symptoms are severe enough.

She said she lost a lot of weight after taking the vaccine and had to undergo several intestinal operations.

"I hate it when people tell me that I'm an isolated case," she said. "I'm not."

To address the question of causality, the courts would likely have to obtain expert advice.

Besides the legal avenue, claimants can also turn to the state for compensation for the loss of income.

More than 8,000 such applications had been made as of April, and so far about five percent have been successful, according to German media.

BioNTech told AFP that the number of liability claims made to the company is very small when compared to the number of doses it has delivered worldwide, and that each claim had to be examined individually.

"Justified liability claims would of course be met by BioNTech," it said, adding however that "no causal relationship between (the) health impairments presented and vaccination with Comirnaty has been proven" in the cases it had reviewed so far.

Another lawyer, Anja Dornhoff, advises her clients to establish a chronology and to get medical practitioners to document the development of their symptoms.

"I hope that people with post-vaccination syndromes can be taken seriously," she said.

(H.Schneide--BBZ)